Pharmatech Repblica Dominicana was hacked. All sensitive company and customer information Listed by alphv Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

People who have done business with Pharmatech República Dominicana, or whose details sit in its internal systems, face a practical question: whether company and customer information has left the organisation’s control and could be misused. Public reporting places the incident in early August 2023 and ties it to a claim by the alphv ransomware group that sensitive material was taken. The number of people affected remains unknown, and the precise contents of what was removed have not been independently confirmed.

For ordinary customers, suppliers, and staff, the stakes are concrete rather than abstract. Pharmaceutical distribution involves contact details, order histories, and business records that can be reused for fraud, phishing, or competitive harm. Until more is verified, anyone connected to the firm has reason to treat the claim seriously and to take basic protective steps.

Breaking down the breach

According to public breach records, Pharmatech República Dominicana was listed by the alphv ransomware group on or around 4 August 2023. The group’s claim states that the company was hacked and that sensitive company and customer information was involved. The same records describe the incident as a ransomware attack in which internal files were allegedly exfiltrated.

No confirmed figure for the number of people affected has been published. The exact method of initial access, the duration of any intrusion, and any ransom demand or payment status are undisclosed in the available facts. What is stated is limited to the listing itself and the characterisation of the data as internal files taken during a ransomware event. Independent verification of the full scope has not been supplied in the material at hand, so the alphv claim remains just that—a claim—pending further confirmation.

Inside alphv

Alphv, also widely known in public reporting as BlackCat, is a ransomware operation that has functioned on a ransomware-as-a-service model. Affiliates gain access to victim networks, deploy encryption malware, and frequently exfiltrate data beforehand so they can threaten to publish it if a ransom is not paid. This double-extortion approach became a hallmark of the group’s activity across multiple sectors.

Public documentation of alphv describes a professionalised set of tactics: customisable ransomware written in modern languages, negotiation portals, and leak sites used to pressure victims by naming them and, in some cases, releasing samples. The group has been linked to numerous incidents worldwide before and around 2023. In this specific case, the only assertion tied directly to Pharmatech República Dominicana is the leak-site listing and the accompanying claim that internal files were taken; no further statements by the group about this victim are provided in the facts.

About Pharmatech Repblica Dominicana

Pharmatech República Dominicana is described in available records as a leading company in the commercialisation of pharmaceutical products in the Dominican Republic. It maintains operations in Santo Domingo and Santiago, with published contact details and a reported revenue figure of approximately $14.1 million. Its public web presence and social channels reflect a business that supplies medicines and related products into the local market.

Organisations of this type sit at the intersection of healthcare supply chains and commercial distribution. They typically manage supplier contracts, customer and pharmacy accounts, inventory and logistics data, employee records, and financial documentation. A breach affecting such a firm is consequential because the sector handles information that can identify business relationships, purchasing patterns, and individuals who rely on timely access to medicines. Disruption or exposure can affect not only the company but also the wider network of pharmacies, clinics, and patients it serves.

What was likely exposed

The facts state that internal files were exfiltrated in a ransomware attack and that the alphv listing referred to sensitive company and customer information. No itemised inventory of those files—nor any confirmed count of records—has been disclosed. Exact contents therefore remain unconfirmed.

Companies engaged in pharmaceutical commercialisation commonly hold materials such as:

• Customer and pharmacy account details, orders, and contact information
• Supplier contracts, pricing, and procurement records
• Employee and internal administrative files
• Financial, logistics, and inventory data

Any of the above could fall under the broad description of “internal files,” but it would be inaccurate to assert that specific categories were definitively taken. Readers should treat the exposure as possible rather than proven in detail.

What's at stake

For individuals whose data may have been involved, the immediate risks include targeted phishing that references real business relationships, identity or account misuse if personal details were present, and unwanted contact from fraudsters posing as suppliers or company staff. Business customers could face competitive exposure if pricing or contract terms were among the files. The organisation itself faces operational, legal, and reputational pressure common to ransomware events: potential regulatory scrutiny, cost of investigation and remediation, and loss of trust among partners who depend on reliable pharmaceutical supply.

Because the scale is unknown and the precise data types unconfirmed, the prudent stance is to assume that some internal material left the environment and to act accordingly, without assuming the worst-case scenario as established fact.

What to do if you're exposed

If you have been a customer, supplier, or employee of Pharmatech República Dominicana, begin with simple, high-value steps. Change passwords on related accounts and enable multi-factor authentication where available. Treat unexpected emails, calls, or messages that reference the company or pharmaceutical orders with caution; verify them through known official channels rather than links or numbers supplied in the message. Monitor financial and account statements for unfamiliar activity. If you receive notification from the company, follow its guidance and keep records of any correspondence.

You can also run a free exposure scan of your email address to check whether it has already appeared in known breach data sets. That check does not confirm or deny involvement in this specific incident, but it can indicate whether your address is circulating more widely and help you prioritise further protections. Stay alert for official updates from the organisation itself, as public detail on this event remains limited.

AICompiled with AI assistance from public sources and published under our editorial standards.